临床试验

VR Therapies for IBD

NCT：NCT07590518 · NOT_YET_RECRUITING

NCT编号NCT07590518

状态NOT_YET_RECRUITING

SponsorBrennan Spiegel (OTHER)

First posted2026-05-15

Last updated2026-05-15

简要摘要

Through a pilot randomized controlled trial (RCT), the aim is to test the clinical impact and feasibility of a AI-enhanced Virtual Reality (VR) Cognitive Behavioral therapy (CBT) program versus distraction VR among patients with inflammatory bowel disease (IBD) and anxiety. It is hypothesized that using VR/AI CBT may reduce anxiety and IBD symptoms, leading to improved overall physical, psychological, and social functioning when compared to distraction VR.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。